SCHEMBL24045237

SCHEMBL24045237

COC(=O)Cc1c(C(=O)OCc2ccccc2)c2ccc(O)c(C)c2oc1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 6/20 0.55
TP53 P04637 2/20 0.55
SHBG P04278 1/20 0.55
STAT3 P40763 1/20 0.51
KDM4E B2RXH2 8/20 0.50
HPGD P15428 7/20 0.50
ALDH1A1 P00352 6/20 0.50
GLA P06280 5/20 0.50
MAPT P10636 4/20 0.50
HIF1A Q16665 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.46
HSD17B10 Q99714 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
HTT P42858 2/20 0.46
MAPK1 P28482 2/20 0.46
POLB P06746 2/20 0.46
JAK2 O60674 1/20 0.46
PKM P14618 1/20 0.46
MPI P34949 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6866676 0.75 SHBG (0.51) GAATP53SHBGKDM4EALDH1A1
SCHEMBL6860101 0.72 SHBG (0.47) GAATP53SHBGKDM4EMAPT
SCHEMBL6937223 0.72 SHBG (0.55) GAATP53SHBGKDM4EALDH1A1
SCHEMBL24045241 0.69 KDM4E (0.68) GAATP53STAT3KDM4EHPGD
SCHEMBL6997503 0.69 SHBG (0.63) GAATP53SHBGKDM4EHPGD
SCHEMBL10651585 0.68 KDM4E (0.72) GAATP53STAT3KDM4EHPGD
SCHEMBL1607267 0.68 MAOB (0.65) GAATP53SHBGNPC1RAB9A
SCHEMBL31435801 0.68 MAOB (0.65) GAATP53SHBGNPC1RAB9A
SCHEMBL19250305 0.67 STAT3 (1.00) TP53STAT3KDM4EHPGDALDH1A1
SCHEMBL22526012 0.67 STAT3 (0.85) TP53STAT3KDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11591304-B2 SLC26A3 inhibitors and use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-02-28 US disclosed
US-20210363123-A1 SLC26A3 INHIBITORS AND USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2021-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210363123-A1 SLC26A3 INHIBITORS AND USE THEREOF SLC26A3, SLC10A2, SLC10A6 GAA 3003/4885TP53 4024/4885SHBG 4368/4885
US-11591304-B2 SLC26A3 inhibitors and use thereof SLC26A3, SLC10A2, SLC10A6 GAA 3003/4885TP53 4024/4885SHBG 4368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.